Literature DB >> 11165128

The effect of local recurrence on survival in resected osteosarcoma.

S Weeden1, R J Grimer, S R Cannon, A H Taminiau, B M Uscinska.   

Abstract

The aim of this study was to assess the effect of local recurrence on survival in primary osteosarcoma. 559 patients entered into two randomised trials of the European Osteosarcoma Intergroup who received surgery for primary operable high-grade osteosarcoma of the extremities were included in this analysis. Proportional hazards modelling techniques were used to assess the relative importance of sex, age, site, surgery performed and local recurrence. The last of these was considered as a time-dependent covariate. 42/559 (8%) patients had a local recurrence. In the multivariate analysis, local recurrence was found to greatly increase the risk of death (hazard ratio (HR)=5.10, 95% confidence interval (CI) 3.51-7.41). Site and surgery performed also had a significant influence within this model. Using the technique of landmark analysis, with the landmark time set at 18 months, local recurrence alone had a significant influence on survival (HR=4.60, 95% CI 2.80-7.57). Local recurrence is an indicator of poorer survival for patients with operable primary osteosarcoma.

Entities:  

Mesh:

Year:  2001        PMID: 11165128     DOI: 10.1016/s0959-8049(00)00362-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  36 in total

1.  [Primary malignant bone tumors].

Authors:  R von Eisenhart-Rothe; A Toepfer; M Salzmann; J Schauwecker; H Gollwitzer; H Rechl
Journal:  Orthopade       Date:  2011-12       Impact factor: 1.087

2.  MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma.

Authors:  Hui Li; Kun Zhang; Li-Hong Liu; Yurong Ouyang; Hong-Bin Guo; Hanchong Zhang; Jie Bu; Tao Xiao
Journal:  Oncol Lett       Date:  2015-06-16       Impact factor: 2.967

3.  Local recurrence has only a small effect on survival in high-risk extremity osteosarcoma.

Authors:  Chang-Bae Kong; Won Seok Song; Wan Hyeong Cho; Jung Moon Oh; Dae-Geun Jeon
Journal:  Clin Orthop Relat Res       Date:  2011-10-19       Impact factor: 4.176

Review 4.  The risk of local recurrence along the core-needle biopsy tract in patients with bone sarcomas.

Authors:  Said Saghieh; Karim Z Masrouha; Khaled M Musallam; Rami Mahfouz; Miguel Abboud; Nabil J Khoury; Rachid Haidar
Journal:  Iowa Orthop J       Date:  2010

5.  Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials.

Authors:  J S Whelan; R C Jinks; A McTiernan; M R Sydes; J M Hook; L Trani; B Uscinska; V Bramwell; I J Lewis; M A Nooij; M van Glabbeke; R J Grimer; P C W Hogendoorn; A H M Taminiau; H Gelderblom
Journal:  Ann Oncol       Date:  2011-10-19       Impact factor: 32.976

6.  CORR Insights®: Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors?

Authors:  Darin Davidson
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

7.  Evaluation of three-dimensional arterial spin labeling perfusion imaging for the pathological investigation of musculoskeletal tumors.

Authors:  Lingbin Xu; Leiming Xu; Haidong Zhu
Journal:  Exp Ther Med       Date:  2018-04-03       Impact factor: 2.447

8.  Usefulness of increased 18F-FDG uptake for detecting local recurrence in patients with extremity osteosarcoma treated with surgical resection and endoprosthetic replacement.

Authors:  Kyoung Jin Chang; Chang-Bae Kong; Wan Hyeong Cho; Dae-Geun Jeon; Soo-Yong Lee; Ilhan Lim; Sang Moo Lim
Journal:  Skeletal Radiol       Date:  2014-11-29       Impact factor: 2.199

9.  What are the factors that affect survival and relapse after local recurrence of osteosarcoma?

Authors:  Akihiko Takeuchi; Valerae O Lewis; Robert L Satcher; Bryan S Moon; Patrick P Lin
Journal:  Clin Orthop Relat Res       Date:  2014-07-01       Impact factor: 4.176

Review 10.  A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma.

Authors:  Hui Li; Kun Zhang; Li-hong Liu; Yurong Ouyang; Jie Bu; Hong-bin Guo; Tao Xiao
Journal:  Tumour Biol       Date:  2014-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.